RECRUITING

Impact of Protect Your Colon™ on CRC Screening

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the research is to assess the impact of Protect Your Colon™, a colorectal cancer (CRC) screening decision aid, on patients' CRC screening behaviors. The Investigators hypothesize that Protect Your Colon™, through optimizing shared decision making, will lead to selection of a test that accurately matches patients' values and increase CRC screening uptake. To test this hypothesis, the investigators will conduct a pilot randomized controlled trial (RCT) to assess if provision of Protect Your Colon™ improves communication on CRC screening, intent to complete screening, and ultimately uptake of screening vs. usual care.

Official Title

Pilot Randomized Controlled Trial Assessing the Impact of Protect Your Colon™ on Colorectal Cancer Screening Behaviors

Quick Facts

Study Start:2023-09-28
Study Completion:2025-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05929820

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:45 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Individuals 45 to 75 years old
  2. * No prior CRC screening or not up-to-date with CRC screening
  3. * Not at high risk for CRC (e.g., inflammatory bowel disease, colon polyposis syndromes, family history of CRC)
  1. * Does not speak English
  2. * Does not have internet access
  3. * Any records flagged "break the glass" or "research opt out."

Contacts and Locations

Study Contact

Christopher V Almario, MD, MSHPM
CONTACT
310.423.4462
Christopher.Almario@csmc.edu
Antwon Chaplin, BA
CONTACT
310.248.6790
Antwon.Chaplin@cshs.org

Principal Investigator

Christopher V Almario, MD, MSHPM
PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center

Study Locations (Sites)

Cedars-Sinai Medical Center
Los Angeles, California, 90048
United States

Collaborators and Investigators

Sponsor: Cedars-Sinai Medical Center

  • Christopher V Almario, MD, MSHPM, PRINCIPAL_INVESTIGATOR, Cedars-Sinai Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-28
Study Completion Date2025-10-01

Study Record Updates

Study Start Date2023-09-28
Study Completion Date2025-10-01

Terms related to this study

Keywords Provided by Researchers

  • Decision aid
  • Stool test
  • Colonoscopy
  • CT scan

Additional Relevant MeSH Terms

  • Colorectal Cancer Screening